The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CymaBay Therapeutics, Inc(NASDAQ:CBAY)


CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, which has com...
Website: http://www.cymabay.com
Founded: 1988
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology
CymaBay Therapeutics Days Payable Outstanding ttm (DPO)
CymaBay Therapeutics Op Cashflow Per Share ttm
CymaBay Therapeutics Free Cashflow Per Share ttm
CymaBay Therapeutics Cash Per Share ttm
CymaBay Therapeutics P/S ratio ttm
CymaBay Therapeutics (GAAP) P/E ratio ttm
CymaBay Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.